Pakistani (KSE) Pharma Industry Analysis
UpdatedMar 29, 2023
DataAggregated Company Financials
Companies10
- 7D-2.7%
- 3M-11.2%
- 1Y-38.6%
- YTD-12.8%
Over the last 7 days, the Pharma industry has dropped 2.7%, driven by a pullback from Searle of 5.3%. However, the industry is down 39% over the past year. As for the next few years, earnings are expected to grow by 40% per annum.
Industry Valuation and Performance
Has the Pakistani Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 29 Mar 2023 | PK₨139.7b | PK₨191.5b | PK₨15.1b | 9.4x | 9.3x | 0.7x |
| Fri, 24 Feb 2023 | PK₨142.4b | PK₨189.4b | PK₨15.2b | 9.2x | 9.3x | 0.8x |
| Sun, 22 Jan 2023 | PK₨138.5b | PK₨189.4b | PK₨15.2b | 8.8x | 9.1x | 0.7x |
| Tue, 20 Dec 2022 | PK₨167.7b | PK₨189.4b | PK₨15.2b | 10.1x | 11x | 0.9x |
| Thu, 17 Nov 2022 | PK₨190.0b | PK₨187.5b | PK₨14.9b | 12.5x | 12.7x | 1x |
| Sat, 15 Oct 2022 | PK₨198.4b | PK₨181.2b | PK₨17.2b | 11.8x | 11.5x | 1.1x |
| Mon, 12 Sep 2022 | PK₨201.7b | PK₨172.4b | PK₨18.5b | 11.7x | 10.9x | 1.2x |
| Wed, 10 Aug 2022 | PK₨210.2b | PK₨169.3b | PK₨21.5b | 10.2x | 9.8x | 1.2x |
| Fri, 08 Jul 2022 | PK₨214.7b | PK₨167.9b | PK₨21.4b | 10.9x | 10x | 1.3x |
| Sun, 05 Jun 2022 | PK₨204.2b | PK₨165.2b | PK₨21.4b | 9.4x | 9.6x | 1.2x |
| Tue, 03 May 2022 | PK₨222.1b | PK₨163.7b | PK₨21.2b | 10.1x | 10.5x | 1.4x |
| Thu, 31 Mar 2022 | PK₨227.6b | PK₨159.8b | PK₨19.6b | 11.1x | 11.6x | 1.4x |
| Sat, 26 Feb 2022 | PK₨228.8b | PK₨160.5b | PK₨20.0b | 11x | 11.4x | 1.4x |
| Mon, 24 Jan 2022 | PK₨239.7b | PK₨160.5b | PK₨20.0b | 11.5x | 12x | 1.5x |
| Wed, 22 Dec 2021 | PK₨234.5b | PK₨160.5b | PK₨20.0b | 11.5x | 11.7x | 1.5x |
| Fri, 19 Nov 2021 | PK₨259.8b | PK₨160.5b | PK₨20.0b | 12.9x | 13x | 1.6x |
| Sun, 17 Oct 2021 | PK₨268.2b | PK₨155.0b | PK₨19.5b | 13.7x | 13.8x | 1.7x |
| Tue, 14 Sep 2021 | PK₨280.4b | PK₨153.6b | PK₨18.7b | 13.9x | 15x | 1.8x |
| Thu, 12 Aug 2021 | PK₨280.5b | PK₨153.6b | PK₨18.7b | 13.4x | 15x | 1.8x |
| Mon, 07 Jun 2021 | PK₨261.6b | PK₨140.6b | PK₨16.9b | 14.8x | 15.5x | 1.9x |
| Sun, 28 Feb 2021 | PK₨278.1b | PK₨135.4b | PK₨15.2b | 16.7x | 18.3x | 2.1x |
| Wed, 02 Dec 2020 | PK₨254.9b | PK₨132.1b | PK₨13.3b | 19.6x | 19.1x | 1.9x |
| Sat, 05 Sep 2020 | PK₨268.4b | PK₨125.7b | PK₨12.1b | 24.1x | 22.3x | 2.1x |
| Tue, 09 Jun 2020 | PK₨213.4b | PK₨124.5b | PK₨9.7b | 19.6x | 22x | 1.7x |
Price to Earnings Ratio
17.5x
Current Industry PE
- Investors are pessimistic on the Pakistani Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 9.3x which is lower than its 3-year average PE of 14.6x.
- The 3-year average PS ratio of 1.5x is higher than the industry's current PS ratio of 0.73x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 16% per year over the last three years.
- Revenues for these companies have grown 15% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Pakistani Healthcare industry?
| PK Market | -1.49% | |
| Healthcare | -2.36% | |
| Pharma | -2.66% | |
| Pharma | -2.66% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| HINOON Highnoon Laboratories | PK₨471.83 | 0.4% +PK₨76.6m | -16.1% | PE8.4x |